Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 10, 2024

BUY
$1.82 - $2.71 $23,674 - $35,251
13,008 Added 60.94%
34,353 $69,000
Q4 2022

Jun 14, 2023

BUY
$1.82 - $2.71 $62,522 - $93,096
34,353 New
34,353 $69,000
Q4 2022

Mar 22, 2023

BUY
$1.82 - $2.71 $23,674 - $35,251
13,008 Added 60.94%
34,353 $69,000
Q4 2022

Feb 15, 2023

BUY
$1.82 - $2.71 $62,522 - $93,096
34,353 New
34,353 $69,000
Q2 2022

May 10, 2024

SELL
$2.86 - $6.44 $26,506 - $59,685
-9,268 Reduced 30.27%
21,345 $81,000
Q2 2022

Jun 20, 2023

BUY
$2.86 - $6.44 $61,046 - $137,461
21,345 New
21,345 $81,000
Q2 2022

Mar 22, 2023

SELL
$2.86 - $6.44 $26,506 - $59,685
-9,268 Reduced 30.27%
21,345 $81,000
Q2 2022

Aug 11, 2022

SELL
$2.86 - $6.44 $26,506 - $59,685
-9,268 Reduced 30.27%
21,345 $82,000
Q1 2022

May 10, 2024

BUY
$5.94 - $12.09 $181,841 - $370,111
30,613 New
30,613 $193,000
Q1 2022

Jun 20, 2023

BUY
$5.94 - $12.09 $181,841 - $370,111
30,613 New
30,613 $193,000
Q1 2022

Mar 22, 2023

SELL
$5.94 - $12.09 $22,215 - $45,216
-3,740 Reduced 10.89%
30,613 $193,000
Q1 2022

May 12, 2022

BUY
$5.94 - $12.09 $181,841 - $370,111
30,613 New
30,613 $193,000

Others Institutions Holding OMIC

About Singular Genomics Systems, Inc.


  • Ticker OMIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 71,193,296
  • Market Cap $1.42B
  • Description
  • Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...
More about OMIC
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.